Eli J. Fine
Impact in
-
- Innovation and Socioeconomic Development
- Aging top 0.5%
Papers in
-
- CRISPR and Genetic Engineering 16
- Advanced biosensing and bioanalysis techniques 7
- RNA Interference and Gene Delivery 4
- RNA and protein synthesis mechanisms 3
- Pluripotent Stem Cells Research 2
-
- Hemophilia Treatment and Research 3
- Co-authors
- Thomas James Cradick (11 shared papers)Gang Bao (8 shared papers)David A. Scott (1 shared paper)Yinqing Li (1 shared paper)Patrick D. Hsu (1 shared paper)Xuebing Wu (1 shared paper)Joshua A. Weinstein (1 shared paper)Silvana Konermann (1 shared paper)
- Journals
- Nucleic Acids Research (4 papers)Molecular Therapy — Nucleic Acids (2 papers)Blood (2 papers)Scientific Reports (2 papers)Advances in experimental medicine and biology (1 paper)
- Partner nations
- United StatesGermanyAustralia
In The Last Decade
Eli J. Fine
18 papers receiving 5.4k citations
Eli J. Fine's Hit Papers
Peers
Comparison fields: 5 of 119
- Business and International Management 504
- Aging 417
- Molecular Biology 5.0k
- Genetics 1.1k
- Virology 131
Countries citing papers authored by Eli J. Fine
This map shows the geographic impact of Eli J. Fine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eli J. Fine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eli J. Fine more than expected).
Fields of papers citing papers by Eli J. Fine
This network shows the impact of papers produced by Eli J. Fine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eli J. Fine. The network helps show where Eli J. Fine may publish in the future.
Co-authors
The 25 scholars most cited alongside Eli J. Fine, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | DNA targeting specificity of RNA-guided Cas9 nucleases Hit paper breakdown → | 2013 | 3801 |
| 2 | CRISPR/Cas9 systems targeting β-globin and CCR5 genes have substantial off-target activity Hit paper breakdown → | 2013 | 503 |
| 3 | 2014 | 322 | |
| 4 | 2014 | 153 | |
| 5 | 2015 | 122 | |
| 6 | 2013 | 114 | |
| 7 | 2014 | 107 | |
| 8 | 2016 | 102 | |
| 9 | 2017 | 66 | |
| 10 | 2018 | 49 | |
| 11 | 2014 | 45 | |
| 12 | 2015 | 37 | |
| 13 | 2016 | 33 | |
| 14 | 2013 | 24 | |
| 15 | 2014 | 5 | |
| 16 | 2020 | 3 | |
| 17 | 2016 | 2 | |
| 18 | Codon swapping of zinc finger nucleases confers expression in primary cells and in vivo from a single lentiviral vector | 2014 | 1 |
| 19 | 2018 | 1 | |
| 20 | 2020 | 0 |
About Eli J. Fine
Eli J. Fine is a scholar working on Molecular Biology, Hematology, Business and International Management, Genetics and Virology, having authored 21 papers that have together received 5.5k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (16 papers), Advanced biosensing and bioanalysis techniques (7 papers), Virus-based gene therapy research (5 papers), RNA Interference and Gene Delivery (4 papers), Hemophilia Treatment and Research (3 papers), Plant Virus Research Studies (3 papers), RNA and protein synthesis mechanisms (3 papers) and Pluripotent Stem Cells Research (2 papers). The work is most often cited by research in Business and International Management (504 citations), Aging (417 citations), Molecular Biology (5.0k citations), Genetics (1.1k citations) and Virology (131 citations). Eli J. Fine has collaborated with scholars based in United States, Germany and Australia. Frequent co-authors include Thomas James Cradick, Gang Bao, David A. Scott, Yinqing Li, Patrick D. Hsu, Xuebing Wu, Joshua A. Weinstein, Silvana Konermann, Luciano A. Marraffini and Feng Zhang. Their work appears in journals such as Nucleic Acids Research, Molecular Therapy — Nucleic Acids, Blood, Scientific Reports and Advances in experimental medicine and biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.